0.00Open0.00Pre Close0 Volume0 Open Interest22.50Strike Price0.00Turnover516.87%IV-48.81%PremiumSep 20, 2024Expiry Date7.38Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7564Delta0.0476Gamma1.86Leverage Ratio-0.3986Theta-0.0013Rho-1.40Eff Leverage0.0040Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet